Erratum for vol. 103, p. 2908

In the article by Ossenkoppele et al entitled “The value of fludarabine in addition to ARA-C and G-CSF in the treatment of patients with high-risk myelodysplastic syndromes and AML in elderly patients,” which appeared in the April 15, 2004, issue of Blood (Volume 103:2908-2913), 3 author names were incorrect and a fourth was missing. The 3 corrected author names are M. Ron Schaafsma, Godefridus J. Peters, and Bronnie van der Holt. The missing author name is Dominik Selleslag, which should have been twelfth in the author list.

This byline error was corrected online in departure from print.